Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome

BACKGROUND: Methylprednisolone remains a commonly used ancillary therapy for paediatric acute respiratory distress syndrome (PARDS), despite a lack of level 1 evidence to justify its use. When planning prospective trials it is useful to define response to therapy and to identify if there is differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitting, Rebecca B., Ray, Samiran, Raffles, Michael, Egan, Helen, Goley, Paul, Peters, Mark, Nadel, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879165/
https://www.ncbi.nlm.nih.gov/pubmed/31770398
http://dx.doi.org/10.1371/journal.pone.0225737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879165/
https://www.ncbi.nlm.nih.gov/pubmed/31770398
http://dx.doi.org/10.1371/journal.pone.0225737

Ejemplares similares